- CEO
- Richard Tyson
- Full Time Employees
- 2,000
- Sector
- Technology
- Industry
- Semiconductors
- Address
- Tubney Woods Abingdon United Kingdom OX13 5QX
- IPO Date
- Feb 17, 2011
- Business
- Oxford Instruments plc designs and manufactures high technology tools and systems that enable the fabrication, analysis, and manipulation of matter at the atomic and molecular level for research and industrial applications; headquartered in Abingdon, Oxfordshire, England, with operations across the United Kingdom, United States, Europe, Asia, and other regions, the company was founded in 1959 as the first substantial commercial spin-out from the University of Oxford and lists on the London Stock Exchange (ticker: OXIG) as a FTSE 250 constituent. Operating through two primary divisions—Imaging & Analysis and Advanced Technologies—it serves sectors including materials & characterisation, research & discovery, semiconductors, healthcare & life sciences, quantum technologies, and industrial applications, targeting academic institutions, government laboratories, and commercial customers in nanotechnology, advanced materials, compound semiconductors, and clean energy. Core products encompass deposition tools such as plasma enhanced chemical vapour deposition (PECVD), inductively coupled plasma chemical vapour deposition (ICPCVD), atomic layer deposition (ALD), and ion beam deposition (IBD); etch tools including inductively coupled plasma etching (ICP RIE), reactive ion etching (RIE), deep silicon etching (DSiE), atomic layer etching (ALE), and ion beam etching (IBE); cryogenic systems and dilution refrigerators like the Proteox suite; benchtop NMR, microanalysis and electron backscatter diffraction (EBSD) detectors, X-ray fluorescence and optical emission spectrometers, coating thickness gauges, MRI and CT systems, low temperature high magnetic field systems, X-ray tubes, plasma processing equipment, VCSELs, atomic force microscopy (AFM), Raman imaging microscopes via WITec, scientific cameras and spectrometers from Andor Technology, scanning probe microscopes from Asylum Research, and nanoindentation instruments from FemtoTools.
Recent developments include the completion of the acquisition of FemtoTools AG in July 2024 for £15.8 million, integrating its MEMS-based nanoindentation technology into the Imaging & Analysis division to enhance materials hardness and stiffness measurement capabilities for semiconductor and research uses; relocation to the new state-of-the-art Severn Beach facility, tripling compound semiconductor processing capacity for datacomms, AI datacentres, power electronics, and augmented reality applications with strong double-digit order growth; and an ongoing operational transformation programme across sites like Belfast's Imaging & Analysis facility, Oxfordshire's quantum operations, and Ulm's Raman facility in Germany, introducing lean processes, improved quality, reduced lead times, and productivity enhancements. In June 2025, the company agreed to divest its quantum-focused subsidiary NanoScience for £60 million amid strategic streamlining efforts. Half-year results for FY26 reflect challenging Q1 trading offset by positive H2 momentum, particularly in compound semiconductors, aligning with full-year expectations.